PMD Device Solutions Valuation

Q: What is the Fair Price of 8T00 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

8T00 (€0.36) is trading below our estimate of [[fair value]] (€8.73)

Is 8T00 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 8T00 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 8T00 (€0.36) is trading below our estimate of fair value (€8.73)

Significantly Below Fair Value: 8T00 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 8T00?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for 8T00. This is calculated by dividing 8T00's market cap by their current preferred multiple.
What is 8T00's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	SEK 90.07m

8T00 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3.1x
Enterprise Value/EBITDA	-4.3x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 8T00's PS Ratio compare to its peers?

The above table shows the PS ratio for 8T00 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	3x
CNW co.don	0.7x	n/a	€6.5m
PA8 Paion	0.2x	30.2%	€2.6m
MDG1 Medigene	4.4x	17.9%	€32.4m
2INV 2invest	6.8x	n/a	€61.5m
8T00 PMD Device Solutions	2.3x	62.0%	€90.1m

Price-To-Sales vs Peers: 8T00 is good value based on its Price-To-Sales Ratio (2.3x) compared to the peer average (3.8x).

Price to Earnings Ratio vs Industry

How does 8T00's PE Ratio compare vs other companies in the DE Biotechs Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	34.4%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	34.4%
	n/a	n/a	n/a

No more companies

Price-To-Sales vs Industry: 8T00 is good value based on its Price-To-Sales Ratio (2.3x) compared to the European Biotechs industry average (9.7x).

Price to Sales Ratio vs Fair Ratio

What is 8T00's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

8T00 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	2.3x
Fair PS Ratio	11.3x

Price-To-Sales vs Fair Ratio: 8T00 is good value based on its Price-To-Sales Ratio (2.3x) compared to the estimated Fair Price-To-Sales Ratio (11.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.